Clinical trial
Efficacity of Taurolock in Preventing Primary Bacterial Peritonitis in Patients Undergoing Peritoneal Dialysis for Renal Insufficiency: a Randomized, Multicenter, Double Blind Study With Placebo
NCT01101087 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacity of Taurolock in Preventing Primary Bacterial Peritonitis in Patients Undergoing Peritoneal Dialysis for Renal Insufficiency: a Randomized, Multicenter, Double Blind Study With Placebo
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- December 31, 2015
- Enrollment
- 150 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.